Pliant Therapeutics Inc (NYSE: PLRX) — Healthcare · Share Price, Chart & Market Data
About: Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.24 (-1.59%)
PLRXPliant Therapeutics Inc
Loading watchlist status…
Trade PLRX now
Pliant Therapeutics Inc share price
PLRX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 11:16 am GMT+0
PLRX price performance
-3.876%
5D
5.983%
1M
-0.8%
YTD
-15.646%
1Y
PLRX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 11:16 am GMT+0
PLRX details
PLRX Market Signals